Abstract
Essential tremor (ET) is the most prevalent tremor disorder. ET has traditionally been viewed as a monosymptomatic disorder characterized by a kinetic arm tremor, but this definition is gradually being replaced. The clinical spectrum has come to include several motor features, including tremor and ataxia, and several non-motor features, including possible cognitive impairment and personality disturbances. Postmortem studies are revealing several different patterns of pathology. The emerging view is that ET might be a family of diseases, unified by the presence of kinetic tremor, but further characterized by etiological, clinical and pathological heterogeneity. Effective pharmacological treatments for the disorder remain limited, although new insights into disease mechanisms might result in more-effective therapies. In addition, recent investigations of environmental toxicants that might be linked to ET open the way towards primary disease prevention through a reduction in exposure to these factors.
Key Points
-
Essential tremor (ET), a progressive disorder of the CNS, is characterized primarily by kinetic tremor of the arms, possibly accompanied by other motor features (e.g. ataxia or rest tremor) and non-motor features (e.g. cognitive impairment and personality disturbances)
-
The clinical diagnosis of ET is based on medical history and physical examination—a 4–12 Hz kinetic tremor is present in the arms, and tremor might also be present in the head, jaw and voice
-
The cause of ET is unclear; the tremor itself it believed to be mediated by a neuronal loop involving cerebellothalamocortical fibers
-
Recent postmortem studies have demonstrated a heterogeneous pathology, with ET cases clustered into two groups: those with cerebellar degenerative changes, and those with brainstem Lewy bodies ('Lewy body variant of ET')
-
The etiology of ET is often genetic; although specific genes associated with ET have not yet been identified, susceptibility loci have been found on chromosomes 3q13, 2p22 and 6p
-
Several environmental toxicants, including harmane and lead, have been tentatively linked with ET
-
The mainstays of therapy for ET are propranolol and primidone, although several promising new agents have been introduced in recent years; surgical treatment (deep brain stimulation) is also effective
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Louis ED et al. (1998) How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 13: 5–10
Louis ED (2001) Essential tremor. N Engl J Med 345: 887–891
Louis ED (2005) Essential tremor. Lancet Neurol 4: 100–110
Schrag A et al. (2000) Essential tremor: an overdiagnosed condition? J Neurol 247: 955–959
Jain S et al. (2006) Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol 63: 1100–1104
Haerer AF et al. (1992) Prevalence of essential tremor: results from the Copiah county study. Arch Neurol 39: 750–751
Louis ED et al. (1995) Differences in the prevalence of essential tremor among elderly African-Americans, whites, and Hispanics in Northern Manhattan, NY. Arch Neurol 52: 1201–1205
Benito-León J et al. (2003) Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 18: 389–394
Dogu O et al. (2003) Prevalence of essential tremor: door-to-door neurological exams in Mersin Province, Turkey. Neurology 61: 1804–1807
Rajput AH et al. (1984) Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 47: 466–470
Benito-León J et al. (2005) Incidence of essential tremor in three elderly populations of central Spain. Neurology 64: 1721–1725
Louis ED et al. (2000) Clinical subtypes of essential tremor. Arch Neurol 57: 1194–1198
Louis ED et al. (2001) Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 49: 761–769
Louis ED et al. (2001) Correlates of functional disability in essential tremor. Mov Disord 16: 914–920
Rajput A et al. (2004) Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 62: 932–936
Singer C et al. (1994) Gait abnormality in essential tremor. Mov Disord 9: 193–196
Deuschl G et al. (2000) Essential tremor and cerebellar dysfunction: clinical and kinematic analysis of intention tremor. Brain 123: 1568–1580
Stolze H et al. (2001) The gait disorder of advanced essential tremor. Brain 124: 2278–2286
Bove M et al. (2006) Posturographic analysis of balance control in patients with essential tremor. Mov Disord 21: 192–198
Gasparini M et al. (2001) Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol 248: 399–402
Lombardi WJ et al. (2001) Cognitive deficits in patients with essential tremor. Neurology 57: 785–790
Lacritz LH et al. (2002) Cognitive functioning in individuals with “benign” essential tremor. J Int Neuropsychol Soc 8: 125–129
Vermilion K et al. (2001) Cognition and affect in idiopathic essential tremor. Mov Disord 16 (Suppl 1): S30
Troster AI et al. (2002) Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol 9: 143–151
Benito-León J et al. (2006) Population-based case-control study of cognitive function in essential tremor. Neurology 66: 69–74
Benito-León J et al. (2006) Elderly onset essential tremor is associated with dementia. Neurology 66: 1500–1505
Benito-León J et al. (2005) Essential tremor is associated with increased risk of incident dementia in a community-based longitudinal study. Neurology 64 (Suppl 1): S253–S254
Louis ED et al. (2003) Regional and racial differences in the prevalence of physician-diagnosed essential tremor in the United States. Mov Disord 18: 1035–1040
Inzelberg R et al.: Essential tremor prevalence is low in Arabic villages in Israel: door-to-door neurological examinations. J Neurol, in press
Tanner CM et al. (2001) Essential tremor in twins: an assessment of genetic vs. environmental determinants of etiology. Neurology 57: 1389–1391
Louis ED (2001) Etiology of essential tremor: should we be searching for environmental causes? Mov Disord 16: 822–829
Busenbark K et al. (1996) Accuracy of reported family histories of essential tremor. Neurology 47: 264–265
Gulcher JR et al. (1997) Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 17: 84–87
Higgins JJ et al. (1998) Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov Disord 13: 972–977
Bain PG et al. (1994) A study of heredity of essential tremor. Brain 117: 805–824
Deng H et al. (2005) Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 65: 651–652
Shatunov A et al. (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 129: 2318–2331
Jeanneteau F et al. (2006) A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci USA 103: 10753–10758
Ma S et al. (2006) Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes? Mov Disord [doi: 10.1002/mds.20950]
Louis ED et al. (2002) Elevation of blood β-carboline alkaloids in essential tremor. Neurology 59: 1940–1944
Louis ED et al. (2005) Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 65: 391–396
Louis ED et al. (2003) Association between essential tremor and blood lead concentration. Environ Health Perspect 111: 1707–1711
Louis ED et al. (2005) Interaction between blood lead concentration and delta-amino-levulinic acid dehydratase gene polymorphisms increases the odds of essential tremor. Mov Disord 20: 1170–1177
Logroscino G (2005) The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ Health Perspect 113: 1234–1238
Graves AB et al. (1991) Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20 (Suppl 2): S58–S61
Louis ED and Ottman R (1996) How familial is familial tremor? Genetic epidemiology of essential tremor. Neurology 46: 1200–1205
Lorenz D et al. (2004) High concordance for essential tremor in monozygotic twins of old age. Neurology 62: 208–211
Louis ED et al. (2005) Essential tremor centralized brain repository: diagnostic validity and clinical characteristics of a highly selected group of essential tremor cases. Mov Disord 20: 1361–1365
Louis ED et al. (2006) Neuropathological findings in essential tremor. Neurology 66: 1756–1759
Louis ED et al. (2006) Essential tremor associated with pathological changes in the cerebellum. Arch Neurol 63: 1189–1193
Helmchen C et al. (2003) Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain 126: 1319–1332
Will AJ et al. (1994) Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 36: 636–642
Pagan FL et al. (2003) Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 60: 1344–1347
Louis ED et al. (2002) Metabolic abnormality in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 333: 17–20
Bucher SF et al. (1997) Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol 41: 32–40
Louis ED et al. (2005) Essential tremor associated with focal non-nigral Lewy bodies: a clinical–pathological study. Arch Neurol 62: 1004–1007
Ross GW et al. (2004) Pathological investigation of essential tremor [abstract]. Neurology 62 (Suppl 5): SA537–SA538
Geraghty JJ et al. (1985) Association between essential tremor and Parkinson's disease. Ann Neurol 17: 329–333
Koller WC et al. (1994) The relationship of essential tremor to other movement disorders: report of 678 patients. Ann Neurol 35: 717–723
Kralic JE et al. (2005) Genetic essential tremor in γ-aminobutyric acid A receptor α1 subunit knockout mice. J Clin Invest 115: 774–779
Louis ED et al. (1998) Is essential tremor symmetric? Observational data from a community-based study of essential tremor. Arch Neurol 55: 1553–1559
Brennan KC et al. (2002) Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study. Mov Disord 17: 313–316
Lou JS and Jankovic J (1991) Essential tremor: clinical correlates in 350 patients. Neurology 41: 234–238
Ashenhurst EM (1973) The nature of essential tremor. Can Med Assoc J 109: 876–878
Hubble JP et al. (1997) Clinical expression of essential tremor: effects of gender and age. Mov Disord 12: 969–972
Louis ED et al. (2003) Factors associated with increased risk of head tremor in essential tremor: a community-based study in northern Manhattan. Mov Disord 18: 432–436
Louis ED et al. (2006) Jaw tremor: prevalence and clinical correlates in three essential tremor case samples. Mov Disord [10.1002/mds.21069]
Louis ED et al. (1997) The Washington Heights Essential Tremor Study: methodologic issues in essential-tremor research. Neuroepidemiology 16: 124–133
Rautakorpi I (1978) Essential tremor: an epidemiological, clinical and genetic study. In Research Reports from the Department of Neurology, University of Turku, Finland, 12. Turku: University of Turku
Critchley M (1949) Observations on essential tremor (heredofamilial tremor). Brain 72: 113–139
Elble RJ (2000) Essential tremor frequency decreases with time. Neurology 55: 1547–1551
Louis ED et al. (2003) Community-based data on associations of disease duration and age with severity of essential tremor: implications for disease pathophysiology. Mov Disord 18: 90–93
Larsson T and Sjogren T (1960) Essential tremor: a clinical and genetic population study. Acta Psychiatr Neurol Scand 36 (Suppl 144): S1–S176
Growdon JH et al. (1975) The effect of alcohol on essential tremor. Neurology 25: 259–262
Koller WC and Biary N (1984) Effect of alcohol on tremors: comparison with propranolol. Neurology 34: 221–222
Klebe S et al. (2005) Influence of alcohol on gait in patients with essential tremor. Neurology 65: 96–101
Koller WC and Rubino FA (1985) Combined resting postural tremors. Arch Neurol 42: 683–684
Rajput AH et al. (1993) Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci 20: 114–117
Cohen O et al. (2003) Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 60: 405–410
Brooks DJ et al. (1992) Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 42: 1554–1560
Chaudhuri KR et al. (2005) Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry 76: 115–117
Shahed J and Jankovic J (2006) Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord [doi: 10.1016/j.parkreldis.2006.05.033]
Chatterjee A et al. (2004) Personality in essential tremor. J Neurol Neurosurg Psychiatry 75: 958–961
Louis ED et al. (2002) Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 59: 1631–1633
Applegate LM and Louis ED (2005) Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Parkinsonism Relat Disord 11: 399–402
Busenbark KL et al. (1992) Olfactory dysfunction in essential tremor. Neurology 42: 1631–1632
Ondo WG et al. (2003) Hearing impairment in essential tremor. Neurology 61: 1093–1097
Benito-León J et al. (2006) Population-based case–control study of reported hearing impairment in essential tremor [abstract #P04.142]. Neurology 66 (Suppl 2): SA234
Deuschl G et al. (1998) Consensus statement of the Movement Disorder Society on tremor. Ad Hoc Scientific Committee. Mov Disord 13 (Suppl): S2–S23
Bain P et al. (2000) Criteria for the diagnosis of essential tremor. Neurology 54 (Suppl 4): S7
Louis ED et al. (1998) Diagnostic criteria for essential tremor: a population perspective. Arch Neurol 55: 823–828
Louis ED et al. (1998) Does a screening questionnaire for essential tremor agree with the physicians' examination? Neurology 50: 1351–1357
Farrer M et al. (1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8: 81–85
Shukla G et al. (2002) Peripheral silent periods in essential tremor. J Neurol Sci 199: 55–58
Manyam BV (1996) Uncommon forms of tremor. In Movement Disorders: Neurologic Principles and Practice, 387–403 (Eds Watts RL and Koller WC) New York: McGraw-Hill
Reid JR and Wheeler SF (2005) Hyperthyroidism: diagnosis and treatment. Am Fam Physician 72: 623–630
Anouti A and Koller WC (1995) Tremor disorders: diagnosis and management. West J Med 162: 510–513
Koller WC et al. (1989) Tremors in early Parkinson disease. Clin Neuropharmacol 12: 293–297
Jankovic J et al. (1999) Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 67: 646–650
Tolosa E et al. (2006) The diagnosis of Parkinson's disease. Lancet Neurol 5: 75–86
Marshall J (1961) The effect of ageing upon physiological tremor. J Neurol Neurosurg Psychiatry 24: 14–17
Elble RJ et al. (2005) Electrophysiologic transition from physiologic tremor to essential tremor. Mov Disord 20: 1038–1042
Deuschl G (2003) Dystonic tremor. Rev Neurol (Paris) 159: 900–905
Walshe JM and Yealland M (1992) Wilson disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 55: 692–696
Benamer TS et al. (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15: 503–510
Antonini A et al. (2001) The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol Sci 22: 47–48
Wang J et al. (2005) 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor. Acta Neurol Scand 112: 380–385
Breit S et al. (2006) [(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor. J Neural Transm 113: 187–193
Louis ED and Pullman S (2001) Comparison of clinical and electrophysiological methods of diagnosing essential tremor. Mov Disord 16: 668–673
Zesiewicz TA et al. (2005) Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 64: 2008–2020
Tolosa ES and Loewenson RB (1975) Essential tremor: treatment with propranolol. Neurology 25: 1041–1044
Packer M et al. on behalf of the membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure (1999) Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83: 1A–38A
Cleeves L and Findley LJ (1988) Propranolol and propranolol-LA in essential tremor: a double blind comparative study. J Neurol Neurosurg Psychiatry 51: 379–384
Findley LH et al. (1985) Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 48: 911–915
Sasso E et al. (1990) Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol 13: 67–76
Gorman WP et al. (1986) A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 49: 64–68
Sasso E et al. (1988) Double-blind comparison of primidone and phenobarbitol in essential tremor. Neurology 38: 808–810
O'Suilleabhain P and Dewey RB Jr (2002) Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord 17: 382–386
Koller WC and Royse VL (1986) Efficacy of primidone in essential tremor. Neurology 36: 121–124
Koller WC and Vetere-Overfield B (1989) Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 39: 1587–1588
Jefferson D et al. (1979) Beta-adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 42: 904–909
Koller WC (1983) Nadolol in essential tremor. Neurology 33: 1076–1077
Leigh PN et al. (1983) Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry 46: 710–715
Biary N et al. (1995) The effect of nimodipine on essential tremor. Neurology 45: 1523–1525
Ceravolo R et al. (1999) Acute and chronic effects of clozapine in essential tremor. Mov Disord 14: 468–472
Pakkenberg H and Pakkenberg B (1986) Clozapine in the treatment of tremor. Acta Neurol Scand 73: 295–297
Louis ED (1999) A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor. Arch Neurol 56: 807–808
Pahwa R et al. (1998) Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 13: 465–467
Ondo W et al. (2000) Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 15: 678–682
Gironell A et al. (1999) A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 56: 475–480
Ondo WG et al. (2006) Topiramate in essential tremor. Neurology 66: 672–677
Huber SJ and Paulson GW (1988) Efficacy of alprazolam for essential tremor. Neurology 38: 241–243
Biary N and Koller W (1987) Kinetic predominant essential tremor: successful treatment with clonazepam. Neurology 37: 471–474
Thompson C et al. (1984) A double-blind trial of clonazepam in benign essential tremor. Clin Neuropharmacol 7: 83–88
Bushara KO et al. (2005) The effect of levetiracetam on essential tremor. Neurology 64: 1078–1080
Yetimalar Y et al. (2005) Olanzapine versus propranolol in essential tremor. Clin Neurol Neurosurg 108: 32–35
Shill HA et al. (2004) Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 62: 2320–2332
Morita S et al. (2005) Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 11: 101–103
Brin MF et al. (2001) A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 56: 1523–1528
Schuurman PR et al. (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342: 461–468
Niranjan A et al. (2000) Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor. Neurology 55: 443–446
Acknowledgements
ED Louis is supported by grants R01 NS39422, R01 NS42859 and P30 ES09089 from the National Institutes of Health, Bethesda, MD, USA. No funding source was involved in the preparation of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Benito-León, J., Louis, E. Essential tremor: emerging views of a common disorder. Nat Rev Neurol 2, 666–678 (2006). https://doi.org/10.1038/ncpneuro0347
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0347
This article is cited by
-
Han family with essential tremor caused by the P421L variant of the TENM4 gene in China
Neurological Sciences (2023)
-
Essential tremor impairs the ability to suppress involuntary action impulses
Experimental Brain Research (2022)
-
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Nature Reviews Neurology (2021)
-
Sleep disturbances in essential tremor: an investigation of associated brain microstructural changes using diffusion tensor imaging
Sleep and Biological Rhythms (2021)
-
Patterns of intrinsic brain activity in essential tremor with resting tremor and tremor-dominant Parkinson’s disease
Brain Imaging and Behavior (2020)